Interferon plus ribavirin (6 vs 12 months) in chronic hepatitis C patients non responders to interferon alone.

被引：0
|
作者：
Picciotto, A
Torre, F
Campo, N
Giusto, R
Brizzolara, R
Sinelli, N
Giudici-Cipriani, A
Grasso, A
De Conca, V
Marenco, G
Menardo, G
Michetti, P
机构：
[1] Univ Genoa, Genoa, Italy
[2] San Paolo Hosp, Savona, Italy
[3] Santa Corona Hosp, Pietra Ligure, Italy
[4] Galliera Hosp, Genoa, Italy
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
412
引用
下载
收藏
页码：263A / 263A
页数：1
相关论文
共 50 条
  • [31] More intensive regimen of interferon (IFN) plus ribavirin (R) could be an alternative in chronic hepatitis C (CHC) patients non responders (NR)to IFN alone. Final report.
    Pinar, A
    Salas, E
    Carmona, I
    Ledro, D
    Rebollo, J
    Gonzalez-Vilchez, J
    Herrerias, JM
    Jimenez-Saenz, M
    HEPATOLOGY, 1999, 30 (04) : 625A - 625A
  • [32] Interferon plus ribavirin retreatment in patients with chronic hepatitis C
    Kullig, U
    Porst, H
    Herrmann, A
    Wiese, M
    Schmidt, U
    Sundermann, U
    HEPATOLOGY, 1998, 28 (04) : 207A - 207A
  • [33] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [34] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    BIODRUGS, 2000, 13 (04) : 299 - 304
  • [35] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [36] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [37] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [38] Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
    De Ledinghen, V
    Trimoulet, P
    Winnock, M
    Bernard, PH
    Bourliere, M
    Portal, I
    Remy, AJ
    Canva, V
    Levy, S
    Foucher, J
    Chene, G
    Couzigou, P
    HEPATOLOGY, 2001, 34 (04) : 586A - 586A
  • [39] Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study
    Andreone, P
    Cursaro, C
    Gramenzi, A
    Fiorino, S
    Di Ciammarino, L
    Miniero, R
    D'Errico, A
    Grigioni, WF
    Gasbarrini, G
    Bernardi, M
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (08): : 688 - 694
  • [40] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy
    Chousterman, N
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
12345